Hormone Therapy Not Tied to Breast Cancer Recurrence, Mortality
FRIDAY, July 29, 2022 -- In postmenopausal women treated for early-stage estrogen receptor-positive breast cancer, neither vaginal estrogen therapy (VET) nor menopausal hormone therapy (MHT) is associated with an increased risk for recurrence or...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news
More News: Breast Cancer | Cancer | Cancer & Oncology | Hormonal Therapy | Hormones | Men | Menopause | Pharmaceuticals | Women